Welcome to GEMSTONE Oncology
GemstoneOncology.com is a dynamic initiative that provides comprehensive educational resources peer-developed by the GEMSTONE Committee for healthcare providers in gynecologic oncology. Explore this site to access downloadable slide modules, case study discussions, and more.
Maintenance Consensus Statement
In a recent commentary in The Oncologist, Drs. Randall, Birrer, and Herzog published a call-to-action to incorporate maintenance therapy into standard practice in ovarian cancer care. In “Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing Practice,” the authors urge their fellow clinicians to…
Endometrial Cancer: Disease State Backgrounder
Endometrial cancer is the most common gynecologic cancer in the United States. Most cases of endometrial cancer are diagnosed at an early stage due to the presence of noticeable symptoms, such as irregular vaginal bleeding. Although the prognosis for patients diagnosed with early-stage disease is good, the prognosis…
Immunotherapy in Gynecologic Cancer: A Focus on Checkpoint Inhibition
Immunotherapy is an emerging treatment option for gynecologic cancers. Immunotherapy aims to eliminate cancer cells by (re)initiating the anticancer response of the patient’s own immune system. Checkpoint inhibitors, a type of immunotherapy, have been FDA-approved for the treatment of a variety of cancer types…
The GEMSTONE Committee
The GEMSTONE Committee is a group of experts in gynecologic oncology who develop the resources found on GemstoneOncology.com. They are dedicated to improving the standard of care for patients with gynecologic cancers through the dissemination of educational content for healthcare providers that addresses key clinical topics.